ST. JUDE MEDICAL, BRASIL LTDA. EPIC STENTED PORCINE HEART VALVE W/FLEXFIT SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number E100-29M |
Device Problems
Device Damaged Prior to Use (2284); Adverse Event Without Identified Device or Use Problem (2993); Material Split, Cut or Torn (4008)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/29/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The investigation results will be provided in the final report.
|
|
Event Description
|
It was reported that on (b)(6) 2021, the patient underwent surgical explant of their 29 mm epic stented porcine heart valve w/flexfit system.The valve was originally placed (b)(6) 2011 and during that same implant procedure, the patient had a maze procedure performed to treat their atrial fibrillation (afib).During a follow up visit on (b)(6) 2021 it was discovered the patient had developed congestive heart failure symptoms.On (b)(6) 2021 the patient underwent a heart catheterization which revealed valve malfunction, specifically moderate to severe grade mitral stenosis and pulmonary hypertension.On (b)(6) 2021, the patient was transferred to a different hospital for further management.It was at this hospital testing revealed mitral valve regurgitation was caused by the prolapsing of the leaflet during the systolic phase of the patients cardiac cycle.Regurgitation was identified in two locations in the anterior leaflet was detected.These findings lead to the patients need for explant of the 29mm epic stented porcine heart valve w/flexfit system.The device was exchanged with a non-abbott device.The patient remained stable throughout the procedure however it was reported the patient encountered difficulty separating from mechanical ventilation due to bleeding in the lung during procedure.The patient was extubated on (b)(6) 2021.No additional information has been provided.
|
|
Manufacturer Narrative
|
Additional information: d9, g3, g6, h2, h3, h6, h10.Explant of the valve was reported due to mitral regurgitation caused by leaflet prolapse.The investigation found that the valve was received fragmented, with the stent broken in two places and the valve tissue damaged.Cusp 2 and 3 contained probable tears, however due to the state of the returned valve it could not be conclusively determined if the tears were present prior to explant.There was fibrous pannus ingrowth on the outflow surface of the sewing cuff near cusp 3.There were degenerative changes to all three cusps.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The degenerative changes to the tissue could have contributed to the suspected tears, and those tears could have contributed to the reported regurgitation, if present prior to explant.
|
|
Search Alerts/Recalls
|
|
|